Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-24-020127

Director sold 80,000 shares at an average $24.32 ($1,945,785)

  • Director acquired 99,624 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
SOUTHWELL DAVID P Director 2024-04-12 Option exercise +70,000 $4.34 $303,940 165,160 D: show line 1 in the form
SOUTHWELL DAVID P Director 2024-04-12 Sale −59,716 $24.22 $1,446,560 105,444 D: show line 2 in the form
SOUTHWELL DAVID P Director 2024-04-12 Sale −10,284 $25.16 $258,704 95,160 D: show line 3 in the form
SOUTHWELL DAVID P Director 2024-04-15 Option exercise +29,624 $4.34 $128,627 124,784 D: show line 4 in the form
SOUTHWELL DAVID P Director 2024-04-15 Sale −10,000 $24.05 $240,520 114,784 D: show line 5 in the form
Open-market sales · 80,000 sh · avg $24.32 · $1,945,785

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
SOUTHWELL DAVID P Director 2024-04-12 Option exercise · Stock Option (Right to Buy) −70,000 $4.34 $303,940 29,624 D: show line 6 in the form
SOUTHWELL DAVID P Director 2024-04-15 Option exercise · Stock Option (Right to Buy) −29,624 $4.34 $128,627 0 D: show line 7 in the form
Loading xslF345X05/form4.xml…